Company intelligence / Profile preview
Magna Pharmaceuticals
Louisville, Kentucky, United Statesmagnaweb.com ↗
- Ownership
- Private
- Employees
- ~10
- Development stage
- Commercial
01
Overview
Magna Pharmaceuticals develops both prescription and non-prescription pharmaceutical products. Its main clinical program involves a fixed-dose combination of atropine/chlorphenamine/pseudoephedrine targeting seasonal allergic rhinitis; this has reached Phase 2 trials but no recent results are published. The company also markets a range of commercialized OTC supplements and topical health/wellness products including Omega‑3s, B12 formulations, skin serums, and allergy relief tablets.
- Therapeutic areas
- OtherNeurologyImmunologyDermatology
- Modalities
- Small moleculeSupplementBiologic
- Industry
- Biotech
02
Drug pipeline
8 assets7 more assets in the full pipeline.
Beyond the preview
Go deeper on Magna Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Magna Pharmaceuticals.